Form D · Biotechnology
AtheroNova Operations, Inc.
Irvine, CA · CIK 0001486956
Offering snapshot reported Jun 2, 2010 · SEC filing
- Reported sold
- $550K Offering amount: $550K
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Feb 5, 2008 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 2, 2010 | Initial | $550,000 | No comparison | 9 | SEC filing |
| Mar 18, 2010 | Initial | $5,000,000 | No comparison | 18 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 04, 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-142823
Source: Form D, filed Jun 2, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Thomas Gardner | Director, Executive, Promoter |
| Boris Ratiner | Director, Promoter |
| Aaron Sandoval | Executive, Promoter |
| Mark Selawski | Executive |
| Giorgio Zadini | Director, Promoter |
| Filiberto Zadini | Director, Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2301 Dupont Drive Suite 525
Irvine, CA, 92612
Irvine, CA, 92612